StockData
Bio Essence Corp logo

Bio Essence Corp (BIOE) stock

BIOEOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$0.42+0.03 (+7.72%)

Close on Oct 19, 2026Market cap $22.70MP/E 10.5Yield –

Bio Essence revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Bio Essence's revenue for the twelve months ending Sep 30, 2026 was $3.03M, up 435.2% year over year. For fiscal 2025 it was $1.90M, up 485.8% from the year before. The highest annual figure on record is $1.90M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.90M+485.8%
FY2024Dec 31, 2024$323.94K-41.3%
FY2023Dec 31, 2023$551.51K-11.3%
FY2022Dec 31, 2022$621.59K-30.0%
FY2021Dec 31, 2021$887.98K-7.4%
FY2020Dec 31, 2020$958.70K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$253.02K+85.0%
Q2 FY2026Jun 30, 2026$794.71K+206.7%
Q1 FY2026Mar 31, 2026$500.54K+2155.8%
Q4 FY2025Dec 31, 2025$1.48M+902.6%
Q3 FY2025Sep 30, 2025$136.80K+1.6%
Q2 FY2025Jun 30, 2025$259.12K+521.5%
Q1 FY2025Mar 31, 2025$22.19K-85.7%
Q4 FY2024Dec 31, 2024$147.56K-43.2%
Q3 FY2024Sep 30, 2024$134.69K-60.5%
Q2 FY2024Jun 30, 2024$41.70K-79.1%
Q3 FY2023Sep 30, 2023$155.70K-18.9%
Q2 FY2023Jun 30, 2023$259.57K-9.9%
Q1 FY2023Mar 31, 2023$341.33K+11.4%
Q4 FY2022Dec 31, 2022$199.16K-6.5%
Q3 FY2022Sep 30, 2022$192.05K-15.4%
Q2 FY2022Jun 30, 2022$288.14K+22.1%
Q1 FY2022Mar 31, 2022$306.41K+44.5%
Q4 FY2021Dec 31, 2021$213.04K-2.7%
Q3 FY2021Sep 30, 2021$226.99K-0.6%
Q2 FY2021Jun 30, 2021$235.93K+15.0%
Q1 FY2021Mar 31, 2021$212.03K-30.8%
Q4 FY2020Dec 31, 2020$218.93K–
Q3 FY2020Sep 30, 2020$228.33K–
Q2 FY2020Jun 30, 2020$205.09K–
Q1 FY2020Mar 31, 2020$306.35K–

More Bio Essence figures

See a number that looks wrong?